We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mechanism Regulates Organelle Distribution during Cell Division

By LabMedica International staff writers
Posted on 24 Jul 2018
Print article
Image: When the enzyme DYRK3 is inhibited, mitotic defects are resulting (red: droplets, green: spindle, blue: DNA) (Photo courtesy of Arpan Rai, University of Zurich).
Image: When the enzyme DYRK3 is inhibited, mitotic defects are resulting (red: droplets, green: spindle, blue: DNA) (Photo courtesy of Arpan Rai, University of Zurich).
A team of Swiss cell biologists has discovered how cells maintain the integrity and distribution of cytoplasmic organelles during and following the process of cell division.

Previous research has shown that liquid–liquid phase separation underlies the formation and disassembly of organelles that lack membranes in cells, but the cellular mechanisms that control this phenomenon are poorly understood. A prominent example of regulated and reversible segregation of liquid phases may occur during mitosis, when this type of organelles disappear upon nuclear-envelope breakdown and reappear as mitosis is completed.

To better understand this phenomenon, investigators at the University of Zurich (Switzerland) focused their attention on a specific enzyme, the dual-specificity kinase DYRK3 (Dual specificity tyrosine-phosphorylation-regulated kinase 3). This enzyme acts as a central solubilizing agent for several types of membraneless organelles during mitosis.

The investigators reported in the July 4, 2018, issue of the journal Nature that DYRK3 kinase activity was essential to prevent the unmixing of the mitotic cytoplasm into aberrant liquid-like hybrid organelles and the over-nucleation of spindle bodies. DYRK3 promoted the mixing of the liquid phases within the cytoplasm to ensure correct separation of chromosomes and uniform division of the cell's components. Following cell division, the enzyme was denatured and individual phases were reestablished. Failure of the phase separation mechanism to function correctly could result in incomplete chromosome separation and incorrect distribution to the daughter cells, which is a common characteristic of numerous cancers.

"These fundamental findings give us completely new insights into cell division: as a process in which the cell contents mix together and then separate again," said senior author Dr. Lucas Pelkmans, professor of molecular life sciences at the University of Zurich. "Thanks to the discovery as to which proteins control phase separation, new strategies can be pursued to prevent mistakes in this process."

Related Links:
University of Zurich

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.